Table 1 Characteristics of patients (n = 312)
Characteristic | No. (%) |
|---|---|
Age (yr) | |
Median (range)/year-old | 47 (25–73) |
 < 50 | 198 (63.5) |
 ≥ 50 | 114 (36.5) |
FIGO stage(2014) | |
IB1 | 226 (72.4) |
IB2 | 45 (14.4) |
IIA1 | 27 (8.7) |
IIA2 | 14 (4.5) |
Histological Grade | |
Low | 32 (10.3) |
Moderate | 142 (45.5) |
High | 138 (44.2) |
Tumor size | |
 < 4 cm | 254 (81.4) |
 ≥ 4 cm | 58 (18.6) |
Stromal invasion | |
Superficial 1/3 and middle 1/3 | 284 (91) |
Deep 1/3 | 28 (9) |
LVSI | |
No | 190 (60.9) |
Yes | 122 (39.1) |
Lymph node metastasis | |
No | 279 (89.4) |
Yes | 33 (10.6) |
Parametrial invasion | 0 |
Positive resection margin | 0 |
Treatment | |
RH | 189 (60.6) |
RH + Adjuvant radio therapy | 123 (39.4) |
RH + concurrent | 33 (26.8) |
radio(chemo)therapy(CCRT) | 90 (73.2) |
Surgery type | |
LRH | 197 (63.1) |
ARH | 115 (36.9) |
Local recurrence | 7 (2.2) |
Distant metastasis | 5 (1.6) |
Death | 4 (1.3) |
Median Follow-up (range)/months | 59.2 (14–77.9) |